Company intelligence / Profile preview

Arxada

Basel, Basel, Switzerlandarxada.com ↗

Ownership: Private
Employees: ~3200
Development stage: Other

Overview

Arxada does not have clinical trial results since it focuses on specialty chemical solutions for microbial control across multiple industries including human health. It offers contract development and manufacturing services with strong quality systems supporting biotech ingredient production.

Therapeutic areas: Infectious DiseasesOther
Modalities: Small molecule ingredientsBiotech-derived microbial control agentsSpecialty chemicals for preservationBiologics-related manufacturing capabilities via CDMO services
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Arxada.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arxada.

Explore the full profile